Sanofi Stock Forms Golden Cross As Dupixent Eyes FDA Green Light: Can The Bullish Run Continue?

Sanofi NV SNY has been flexing its biotech muscles, and investors are taking notice. The stock is firmly in bullish territory, recently forming a Golden Cross, a classic technical signal that often precedes further gains.With momentum traders piling in and Sanofi's latest Dupixent breakthrough adding serious fuel to the rally, the stock is in the spotlight.Sanofi Stock Chart Screams Bullish Chart created using Benzinga ProSanofi stock is up 21.89% year-to-date. Its eight-day, 20-day, 50-day and even 200-day ...